Sierra Summit Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.94M Buy
15,509
+150
+1% +$35K 0.44% 43
2026
Q1
$3.75M Buy
15,359
+1,166
+8% +$272K 0.55% 43
2025
Q4
$2.94M Buy
14,193
+256
+2% +$50.6K 0.45% 43
2025
Q3
$2.58M Buy
13,937
+172
+1% +$29.5K 0.39% 46
2025
Q2
$2.1M Sell
13,765
-295
-2% -$45.3K 0.37% 45
2025
Q1
$2.33M Buy
14,060
+133
+1% +$20.8K 0.51% 42
2024
Q4
$2.01M Buy
13,927
+2,682
+24% +$416K 0.4% 44
2024
Q3
$1.82M Buy
11,245
+2,050
+22% +$327K 0.42% 42
2024
Q2
$1.34M Buy
9,195
+656
+8% +$97.6K 0.33% 48
2024
Q1
$1.35M Sell
8,539
-154
-2% -$24.5K 0.37% 42
2023
Q4
$1.36M Buy
+8,693
New +$1.33M 0.4% 43

Other funds holding JNJ

Sierra Summit Advisors's JNJ Position: Q2 2026 in Review

Sierra Summit Advisors increased its Johnson & Johnson (JNJ) stake by 0.98% in Q2 2026, buying an estimated $35K and bringing the position to 15,509 shares worth $3.94M. The position accounts for 0.44% of the portfolio, ranked #43.

Sierra Summit Advisors first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sierra Summit Advisors held 15,509 shares of Johnson & Johnson worth $3.94M as of Q2 2026.
  • Sierra Summit Advisors bought 150 Johnson & Johnson shares in Q2 2026, an estimated $35K.
  • Johnson & Johnson made up 0.44% of Sierra Summit Advisors's portfolio in Q2 2026, its #43 holding.
  • Sierra Summit Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sierra Summit Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.